OLEPTISS

OLEPTISS® 360 mg, containing deferasirox, is an oral iron chelation therapy presented in a pack of 30 film-coated tablets. It is indicated for treating chronic iron overload caused by frequent blood transfusions in patients with conditions like beta-thalassemia and other chronic anemias. It is also used for non-transfusion-dependent thalassemia syndromes. OLEPTISS works by binding to excess trivalent iron, forming a stable complex that the body eliminates, preventing organ damage from iron toxicity. This medication requires strict medical supervision, routine monitoring of kidney and liver functions, and regular blood tests to track serum ferritin levels.